Quarter
Charts

ALIGNMENT HEALTHCARE, INC.

ALHC

CIK 0001832466 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$1.24B
↑+33.3% +$308Mvs FY2025 (Q1)
Operating Income
$16M
↓-98.1% -$800Mvs FY2025 (Q1)
Net Income
$11M
Gross Profit
$1.24B
↑+33.3% +$308Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
62/100
  • Profitability
    0ROIC 2.5% (10% = solid, 20%+ = moat)
  • Liquidity
    60Current Ratio 1.71 (above 1.5 = solid)
  • Leverage
    10D/E 1.80 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 4.27x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +33.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 1.3% · trend +3.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ALHC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$9.83
Total enterprise IV
$1.95B
Diluted shares
0.20B
Terminal PV
$1.41B (72% of total)
Year-5 FCF
$166M
YearProjected FCFDiscounted PV
+1$122M$111M
+2$132M$109M
+3$143M$107M
+4$154M$105M
+5$166M$103M
Terminal$2.27B$1.41B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$26M
investment in PP&E
Stock buybacks (TTM)
—
share count reduction
Stock-based comp (TTM)
$59M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$1.26B
everything owned
Total liabilities
$1.05B
everything owed
Stockholders' equity
$207M
shareholder claim
Net debt
$-382M
Net cash position ($382M)

Recent performance · 26 quarters

Revenue↑+33.3% +$308M
$1.24B
Net Income↑+225.3% +$21M
$11M
Free Cash Flow↑+1350.5% +$113M
$121M
Operating Margin↑+1.8pts
1.3%

Drill down

ALHC Sankey

See ALIGNMENT HEALTHCARE, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

ALHC Charts

26 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

ALHC Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics